Global HIV Integrase Strand Transfer Inhibitors (INSTI) Professional Survey Report 2022, Forecast to 2027

Code: RW00014683897
Multimarket Insight
Jun-2022
Life Sciences
138 Pages

Integrase strand transfer inhibitors?(INSTIs) are a newer class of antiretroviral drugs that block?HIV?replication. They block?integrase, an?HIV-coded enzyme, and thereby prevent the virus from incorporating its genetic information into the host cell DNA. These drugs have played a key role in?HIV?therapy.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the HIV Integrase Strand Transfer Inhibitors (INSTI) industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.

Market Segment by Product Type
Raltegravir
Elvitegravir Combination Drugs
Dolutegravir and Its Combination Drug
Bictegravir Combination Drug
Cabotegravir
Other

Market Segment by Product Application
Hospital
Clinic
Drug Center
Other

Finally, the report provides detailed profile and data information analysis of leading company.
Adcock Ingram Limited
Flamingo Pharmaceuticals Limited
Biocon Limited
Affine Formulations Limited
Emcure Pharmaceuticals
Aurobindo Pharma
Hetero Drugs
Cipla
Bristol-Myers Squibb
Gilead Sciences
Merck
Shanghai Desano Pharmaceuticals
IPCA Laboratories
Mylan
Medisist Pharma
Janssen Pharmaceutica (Johnson & Johnson)
ViiV Healthcare (GSK)
Ranbaxy Pharmaceuticals
LAURUS Labs

Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.

Research Objectives
1.To study and analyze the global HIV Integrase Strand Transfer Inhibitors (INSTI) consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of HIV Integrase Strand Transfer Inhibitors (INSTI) market by identifying its various subsegments.
3.Focuses on the key global HIV Integrase Strand Transfer Inhibitors (INSTI) manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the HIV Integrase Strand Transfer Inhibitors (INSTI) with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of HIV Integrase Strand Transfer Inhibitors (INSTI) submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global HIV Integrase Strand Transfer Inhibitors (INSTI) Professional Survey Report Report 2022, Forecast to 2027

1 Market Study Overview
1.1 Study Objectives
1.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Segment by Type
2.1.1 Raltegravir
2.1.2 Elvitegravir Combination Drugs
2.1.3 Dolutegravir and Its Combination Drug
2.1.4 Bictegravir Combination Drug
2.1.5 Cabotegravir
2.1.6 Other
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Clinic
2.2.3 Drug Center
2.2.4 Other
2.3 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Comparison by Regions (2017-2027)
2.3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2017-2027)
2.3.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2017-2027)
2.3.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2017-2027)
2.3.4 Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2017-2027)
2.3.5 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2017-2027)
2.3.6 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Impact
2.5.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Business Impact Assessment - Covid-19
2.5.2 Market Trends and HIV Integrase Strand Transfer Inhibitors (INSTI) Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Market Share by Manufacturer (2017-2022)
3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 HIV Integrase Strand Transfer Inhibitors (INSTI) Manufacturer Market Share
3.5 Top 10 HIV Integrase Strand Transfer Inhibitors (INSTI) Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into HIV Integrase Strand Transfer Inhibitors (INSTI) Market
3.7 Key Manufacturers HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
3.8 Mergers & Acquisitions Planning

4 Analysis of HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Key Manufacturers
4.1 Adcock Ingram Limited
4.1.1 Company Details
4.1.2 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.1.3 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Adcock Ingram Limited News
4.2 Flamingo Pharmaceuticals Limited
4.2.1 Company Details
4.2.2 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.2.3 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Flamingo Pharmaceuticals Limited News
4.3 Biocon Limited
4.3.1 Company Details
4.3.2 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.3.3 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Biocon Limited News
4.4 Affine Formulations Limited
4.4.1 Company Details
4.4.2 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.4.3 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Affine Formulations Limited News
4.5 Emcure Pharmaceuticals
4.5.1 Company Details
4.5.2 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.5.3 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Emcure Pharmaceuticals News
4.6 Aurobindo Pharma
4.6.1 Company Details
4.6.2 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.6.3 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Aurobindo Pharma News
4.7 Hetero Drugs
4.7.1 Company Details
4.7.2 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.7.3 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Hetero Drugs News
4.8 Cipla
4.8.1 Company Details
4.8.2 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.8.3 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Cipla News
4.9 Bristol-Myers Squibb
4.9.1 Company Details
4.9.2 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.9.3 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Bristol-Myers Squibb News
4.10 Gilead Sciences
4.10.1 Company Details
4.10.2 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.10.3 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Gilead Sciences News
4.11 Merck
4.11.1 Company Details
4.11.2 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.11.3 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Merck News
4.12 Shanghai Desano Pharmaceuticals
4.12.1 Company Details
4.12.2 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.12.3 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Shanghai Desano Pharmaceuticals News
4.13 IPCA Laboratories
4.13.1 Company Details
4.13.2 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.13.3 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 IPCA Laboratories News
4.14 Mylan
4.14.1 Company Details
4.14.2 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.14.3 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Mylan News
4.15 Medisist Pharma
4.15.1 Company Details
4.15.2 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.15.3 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Medisist Pharma News
4.16 Janssen Pharmaceutica (Johnson & Johnson)
4.16.1 Company Details
4.16.2 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.16.3 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.16.4 Main Business Overview
4.16.5 Janssen Pharmaceutica (Johnson & Johnson) News
4.17 ViiV Healthcare (GSK)
4.17.1 Company Details
4.17.2 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.17.3 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.17.4 Main Business Overview
4.17.5 ViiV Healthcare (GSK) News
4.18 Ranbaxy Pharmaceuticals
4.18.1 Company Details
4.18.2 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.18.3 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.18.4 Main Business Overview
4.18.5 Ranbaxy Pharmaceuticals News
4.19 LAURUS Labs
4.19.1 Company Details
4.19.2 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification
4.19.3 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.19.4 Main Business Overview
4.19.5 LAURUS Labs News

5 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Categorized by Regions
5.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Sales and Market Share by Regions
5.1.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Market Share by Regions (2017-2022)
5.1.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Market Share by Regions (2017-2022)
5.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
5.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
5.4 Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
5.5 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)

6 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Categorized by Countries
6.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Revenue and Market Share by Countries
6.1.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (Volume) by Countries (2017-2022)
6.1.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2017-2022)
6.1.3 United States HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
6.1.4 Canada HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
6.1.5 Mexico HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
6.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Value) by Manufacturers
6.3 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Market Share by Type (2017-2022)
6.4 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Application (2017-2022)

7 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Categorized by Countries
7.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Revenue and Market Share by Countries
7.1.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (Volume) by Countries (2017-2022)
7.1.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2017-2022)
7.1.3 Germany HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
7.1.4 UK HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
7.1.5 France HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
7.1.6 Russia HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
7.1.7 Italy HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
7.1.8 Spain HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
7.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Value) by Manufacturers
7.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Market Share by Type (2017-2022)
7.4 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Application (2017-2022)

8 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Categorized by Countries
8.1 Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2017-2022)
8.1.3 China HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
8.1.4 South Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
8.1.5 Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
8.1.6 Australia HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
8.1.7 India HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
8.2 Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Value) by Manufacturers
8.3 Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Application (2017-2022)

9 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Categorized by Countries
9.1 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Revenue and Market Share by Countries
9.1.1 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (Volume) by Countries (2017-2022)
9.1.2 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2017-2022)
9.1.3 Brazil HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
9.2 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Market Share by Type (2017-2022)
9.3 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Application (2017-2022)

10 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Categorized by Countries
10.1 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2017-2022)
10.1.3 GCC Countries HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
10.1.4 Turkey HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
10.1.5 Egypt HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
10.1.6 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Market Share by Type
10.3 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Application (2017-2022)

11 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Segment by Type
11.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Market Share by Type (2017-2022)
11.1.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Market Share by Type (2017-2022)
11.2 Raltegravir Sales Growth Rate and Price
11.2.1 Global Raltegravir Sales Growth Rate (2017-2022)
11.2.2 Global Raltegravir Price (2017-2022)
11.3 Elvitegravir Combination Drugs Sales Growth Rate and Price
11.3.1 Global Elvitegravir Combination Drugs Sales Growth Rate (2017-2022)
11.3.2 Global Elvitegravir Combination Drugs Price (2017-2022)
11.4 Dolutegravir and Its Combination Drug Sales Growth Rate and Price
11.4.1 Global Dolutegravir and Its Combination Drug Sales Growth Rate (2017-2022)
11.4.2 Global Dolutegravir and Its Combination Drug Price (2017-2022)
11.5.1 Global Bictegravir Combination Drug Sales Growth Rate (2017-2022)
11.5.2 Global Bictegravir Combination Drug Price (2017-2022)
11.6 Cabotegravir Sales Growth Rate and Price
11.6.1 Global Cabotegravir Sales Growth Rate (2017-2022)
11.6.2 Global Cabotegravir Price (2017-2022)
11.7 Other Sales Growth Rate and Price
11.7.1 Global Other Sales Growth Rate (2017-2022)
11.7.2 Global Other Price (2017-2022)

12 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Segment by Application
12.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Application (2017-2022)
12.2 Hospital Sales Growth Rate (2017-2022)
12.3 Clinic Sales Growth Rate (2017-2022)
12.4 Drug Center Sales Growth Rate (2017-2022)
12.5 Other Sales Growth Rate (2017-2022)

13 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast
13.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Sales and Growth Rate (2022-2027)
13.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast by Regions (2022-2027)
13.2.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast (2022-2027)
13.2.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast (2022-2027)
13.2.3 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast (2022-2027)
13.2.4 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast (2022-2027)
13.2.5 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast (2022-2027)
13.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast by Type (2022-2027)
13.3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Forecast by Type (2022-2027)
13.3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share Forecast by Type (2022-2027)
13.4 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast by Application (2022-2027)
13.4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Forecast by Application (2022-2027)
13.4.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share Forecast by Application (2022-2027)

14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis

15 HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 HIV Integrase Strand Transfer Inhibitors (INSTI) Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers

List of Tables and Figures

Figure Product Picture HIV Integrase Strand Transfer Inhibitors (INSTI)
Figure Market Concentration Ratio and Market Maturity Analysis of HIV Integrase Strand Transfer Inhibitors (INSTI)
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
Figure Global Market Share of HIV Integrase Strand Transfer Inhibitors (INSTI) by Type in 2021
Figure Raltegravir Picture
Figure Elvitegravir Combination Drugs Picture
Figure Dolutegravir and Its Combination Drug Picture
Figure Bictegravir Combination Drug Picture
Figure Cabotegravir Picture
Figure Other Picture
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (Volume) by Application
Figure Hospital Picture
Figure Clinic Picture
Figure Drug Center Picture
Figure Other Picture
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Comparison by Regions (M USD) 2017-2027
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (Million US$) (2017-2027)
Figure North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million US$) Growth Rate (2017-2027)
Figure South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and HIV Integrase Strand Transfer Inhibitors (INSTI) Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Manufacturer (2017-2022)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Manufacturer in 2021
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Manufacturer (2017-2022)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Manufacturer in 2021
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 HIV Integrase Strand Transfer Inhibitors (INSTI) Manufacturer (Revenue) Market Share in 2021
Figure Top 10 HIV Integrase Strand Transfer Inhibitors (INSTI) Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into HIV Integrase Strand Transfer Inhibitors (INSTI) Market
Table Key Manufacturers HIV Integrase Strand Transfer Inhibitors (INSTI) Product Type
Table Mergers & Acquisitions Planning
Table Adcock Ingram Limited Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Adcock Ingram Limited
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Adcock Ingram Limited 2017-2022
Table Adcock Ingram Limited Main Business
Table Adcock Ingram Limited Recent Development
Table Flamingo Pharmaceuticals Limited Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Flamingo Pharmaceuticals Limited
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Flamingo Pharmaceuticals Limited 2017-2022
Table Flamingo Pharmaceuticals Limited Main Business
Table Flamingo Pharmaceuticals Limited Recent Development
Table Biocon Limited Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Biocon Limited
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Biocon Limited 2017-2022
Table Biocon Limited Main Business
Table Biocon Limited Recent Development
Table Affine Formulations Limited Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Affine Formulations Limited
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Affine Formulations Limited 2017-2022
Table Affine Formulations Limited Main Business
Table Affine Formulations Limited Recent Development
Table Emcure Pharmaceuticals Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Emcure Pharmaceuticals
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Emcure Pharmaceuticals 2017-2022
Table Emcure Pharmaceuticals Main Business
Table Emcure Pharmaceuticals Recent Development
Table Aurobindo Pharma Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Aurobindo Pharma
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Aurobindo Pharma 2017-2022
Table Aurobindo Pharma Main Business
Table Aurobindo Pharma Recent Development
Table Hetero Drugs Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Hetero Drugs
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Hetero Drugs 2017-2022
Table Hetero Drugs Main Business
Table Hetero Drugs Recent Development
Table Cipla Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Cipla
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Cipla 2017-2022
Table Cipla Main Business
Table Cipla Recent Development
Table Bristol-Myers Squibb Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Bristol-Myers Squibb
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2017-2022
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table Gilead Sciences Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Gilead Sciences
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Gilead Sciences 2017-2022
Table Gilead Sciences Main Business
Table Gilead Sciences Recent Development
Table Merck Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Merck
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Merck 2017-2022
Table Merck Main Business
Table Merck Recent Development
Table Shanghai Desano Pharmaceuticals Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Shanghai Desano Pharmaceuticals
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Shanghai Desano Pharmaceuticals 2017-2022
Table Shanghai Desano Pharmaceuticals Main Business
Table Shanghai Desano Pharmaceuticals Recent Development
Table IPCA Laboratories Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of IPCA Laboratories
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of IPCA Laboratories 2017-2022
Table IPCA Laboratories Main Business
Table IPCA Laboratories Recent Development
Table Mylan Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Mylan
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Mylan 2017-2022
Table Mylan Main Business
Table Mylan Recent Development
Table Medisist Pharma Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Medisist Pharma
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Medisist Pharma 2017-2022
Table Medisist Pharma Main Business
Table Medisist Pharma Recent Development
Table Janssen Pharmaceutica (Johnson & Johnson) Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Janssen Pharmaceutica (Johnson & Johnson)
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Janssen Pharmaceutica (Johnson & Johnson) 2017-2022
Table Janssen Pharmaceutica (Johnson & Johnson) Main Business
Table Janssen Pharmaceutica (Johnson & Johnson) Recent Development
Table ViiV Healthcare (GSK) Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of ViiV Healthcare (GSK)
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of ViiV Healthcare (GSK) 2017-2022
Table ViiV Healthcare (GSK) Main Business
Table ViiV Healthcare (GSK) Recent Development
Table Ranbaxy Pharmaceuticals Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of Ranbaxy Pharmaceuticals
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ranbaxy Pharmaceuticals 2017-2022
Table Ranbaxy Pharmaceuticals Main Business
Table Ranbaxy Pharmaceuticals Recent Development
Table LAURUS Labs Company Profile
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Product Introduction, Application and Specification of LAURUS Labs
Table HIV Integrase Strand Transfer Inhibitors (INSTI) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of LAURUS Labs 2017-2022
Table LAURUS Labs Main Business
Table LAURUS Labs Recent Development
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2017-2022)
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Regions (2017-2022)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Regions in 2021
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Regions (2017-2022)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Regions in 2021
Figure North America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
Figure Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
Figure Asia-pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
Figure South America HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
Figure Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Sales and Growth Rate (2017-2022)
Figure North America HIV Integrase Strand Transfe

Adcock Ingram Limited
Flamingo Pharmaceuticals Limited
Biocon Limited
Affine Formulations Limited
Emcure Pharmaceuticals
Aurobindo Pharma
Hetero Drugs
Cipla
Bristol-Myers Squibb
Gilead Sciences
Merck
Shanghai Desano Pharmaceuticals
IPCA Laboratories
Mylan
Medisist Pharma
Janssen Pharmaceutica (Johnson & Johnson)
ViiV Healthcare (GSK)
Ranbaxy Pharmaceuticals
LAURUS Labs

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE